Clinical trial
Comparison of the Effect Between Levofloxacin and Moxifloxacin on the Culture Conversion After 3 Months Treatment Among MDR-TB Patients; Prospective Multicenter Randomized Open Label Phase III Trial
NCT01055145 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of the Effect Between Levofloxacin and Moxifloxacin on the Culture Conversion After 3 Months Treatment Among MDR-TB Patients; Prospective Multicenter Randomized Open Label Phase III Trial
- Lead sponsor
- Seoul National University Hospital
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- March 31, 2010
- Completion date
- October 31, 2012
- Enrollment
- 182 (actual)
- Sites
- 29
Conditions
As the registry lists them; a condition with its own page is linked.
tb